专利检索 ap:("Protagonist Therapeutics, Inc.") AND inv:"BOURNE, Gregory" 第 1 页

1.

发明公开
PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES 审中-公开

公开(公告)号：EP3570864A1

公开(公告)日：2019-11-27

申请号：EP18741939.5

申请日：2018-01-18

申请人： Protagonist Therapeutics, Inc.

发明人： BHANDARI, Ashok , BOURNE, Gregory

IPC分类号： A61K38/00 , A61P1/00 , C07K7/02 , C07K7/08 , C07K7/50 , C07K7/64 , C07K14/54

2.

发明公开
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES 审中-实审

公开(公告)号：EP4378536A2

公开(公告)日：2024-06-05

申请号：EP24156804.7

申请日：2015-07-15

申请人： Protagonist Therapeutics, Inc.

发明人： BOURNE, Gregory , BHANDARI, Ashok , CHENG, XiaoLi , FREDERICK, Brian Troy , ZHANG, Jie , PATEL, Dinesh V. , LIU, David

IPC分类号： A61P43/00

CPC分类号： G01N2800/06520130101 , C07K14/54 , A61K38/00 , A61P1/00 , A61P1/04 , A61P1/16 , A61P1/18 , A61P11/00 , A61P11/02 , A61P11/06 , A61P15/14 , A61P17/06 , A61P19/02 , A61P35/00 , A61P37/06 , A61P43/00 , A61P5/48 , A61P3/10

摘要： The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease.

3.

发明公开
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES 审中-公开
标题翻译：白细胞介素-23受体的口服肽抑制剂及其用途的炎症性肠疾病的治疗

公开(公告)号：EP3169403A1

公开(公告)日：2017-05-24

申请号：EP15821351.2

申请日：2015-07-15

申请人： Protagonist Therapeutics Inc.

发明人： BOURNE, Gregory , BHANDARI, Ashok , CHENG, XiaoLi , FREDERICK, Brian Troy , ZHANG, Jie , PATEL, Dinesh V. , LIU, David

IPC分类号： A61P1/00

CPC分类号： C07K7/08 , A61K38/00 , C07K7/02 , C07K7/50 , C07K7/64 , C07K14/54 , G01N2800/065

摘要： The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease.

摘要翻译： 本发明提供了白介素23受体的新的肽酶抑制剂，以及相关的组合物和使用这些肽的抑制剂以治疗或预防多种疾病和病症，包括炎性肠病的方法。

4.

发明公开
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES 审中-公开

公开(公告)号：EP4378536A3

公开(公告)日：2024-10-09

申请号：EP24156804.7

申请日：2015-07-15

申请人： Protagonist Therapeutics, Inc.

发明人： BOURNE, Gregory , BHANDARI, Ashok , CHENG, XiaoLi , FREDERICK, Brian Troy , ZHANG, Jie , PATEL, Dinesh V. , LIU, David

IPC分类号： C07K14/54 , A61K47/60 , A61P1/00 , A61P37/06 , A61P43/00 , A61K38/00

CPC分类号： G01N2800/06520130101 , C07K14/54 , A61K38/00 , A61P1/00 , A61P1/04 , A61P1/16 , A61P1/18 , A61P11/00 , A61P11/02 , A61P11/06 , A61P15/14 , A61P17/06 , A61P19/02 , A61P35/00 , A61P37/06 , A61P43/00 , A61P5/48 , A61P3/10

摘要： The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease.

5.

发明公开
PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES 审中-公开

公开(公告)号：EP3341011A2

公开(公告)日：2018-07-04

申请号：EP16825301.1

申请日：2016-07-15

申请人： Protagonist Therapeutics Inc.

发明人： BHANDARI, Ashok , BOURNE, Gregory , CHENG, XiaoLi , FREDERICK, Brian Troy , ZHANG, Jie , PATEL, Dinesh V. , LIU, David

IPC分类号： A61K38/20 , C07K7/08 , C07K14/54

CPC分类号： C07K7/06 , C07K7/08

摘要： The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.